These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 411569)

  • 1. Modifications of 3'-methyl-4-dimethylaminoazobenzene carcinogenesis of rat liver and carcinogen metabolism by portacaval anastomosis.
    Ricco JB; Franco D; Morin J; Decloître F; Bismuth H
    Cancer Res; 1977 Dec; 37(12):4500-5. PubMed ID: 411569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of Aflatoxin B1 induced liver carcinogenesis by portal diversion in the rat.
    Franco D; Morin J; Szekely AM; Bismuth H
    Biomedicine; 1981 Oct; 35(5):162-5. PubMed ID: 6172161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary influences on the hepatic mixed-function oxidase system in the rat after portacaval anastomosis.
    Proia AD; Edwards KD; McNamara DJ; Anderson KE
    Gastroenterology; 1984 Apr; 86(4):618-26. PubMed ID: 6698363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between alpha-fetoprotein positive cells and precancerous lesions in rat liver during 3'-methyl-4-dimethylaminoazobenzene carcinogenesis.
    Stratil P; Dolezalová V; Nĕmecek R; Simícková M
    Neoplasma; 1979; 26(4):381-91. PubMed ID: 93242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased activation of carcinogens in the liver of carcinogen-resistant rats.
    Yano M; Higashi T; Kano S; Tateishi N; Kido Y; Mori T; Higashi K; Sakamoto Y
    Cancer Res; 1989 Oct; 49(19):5352-7. PubMed ID: 2548720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of the azocarcinogen 3'-methyl-p-dimethylaminoazobenzene to cellular components of normal rat liver and azocarcinogen-induced hepatomas.
    Carruthers C; Baumler A; Neilson A; Pressman D
    Cancer Res; 1975 Dec; 35(12):3798-06. PubMed ID: 172235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in RNA synthesis at early stages of aminoazocancerogenesis].
    Mironov NM; Asler VV; Sokolov NA; Zaboĭkin MM; Shapot VS
    Biokhimiia; 1975; 40(4):861-8. PubMed ID: 812558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic functional deterioration after portacaval shunt in the rat. Effects on sulfobromophthalein transport-maximum, indocyanine green clearance and galactose elimination capacity.
    Lauterburg BH; Sautter V; Preisig R; Bircher J
    Gastroenterology; 1976 Aug; 71(2):221-7. PubMed ID: 939381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of drug-metabolizing activities in the livers of carcinogen-sensitive parent rats and carcinogen-resistant descendants.
    Yoshimoto F; Masuda S; Higashi T; Nishii T; Takamisawa I; Tateishi N; Sakamoto Y
    Cancer Res; 1985 Dec; 45(12 Pt 1):6155-9. PubMed ID: 3933822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of portacaval transposition on hepatic cytochrome P-450 in the rat.
    Pector JC; Ossenberg FW; Peignoux M; Benhamou JP
    Biomedicine; 1975 Jun; 23(5):160-2. PubMed ID: 1191728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Corynebacterium parvum in prevention and reversal of atrophy of the liver following portacaval shunt.
    Fisher B; Gebhardt MC; Saffer EA; Fisher ER
    Surg Gynecol Obstet; 1979 Aug; 149(2):168-72. PubMed ID: 462347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of circadian locomotor activity in rats after portacaval anastomosis is not gender dependent.
    Steindl PE; Gottstein J; Blei AT
    Hepatology; 1995 Dec; 22(6):1763-8. PubMed ID: 7489986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of 3'-methyl-4-dimethylaminoazobenzene, 2-methyl-4-dimethylaminoazobenzene, and 2-acetylaminofluorene on rat liver DNA stability and new synthesis.
    Yager JD; Potter VR
    Cancer Res; 1975 May; 35(5):1225-34. PubMed ID: 804349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in hepatic blood flow after various types of portal shunt in the rat].
    Castaing D; Crestanello F; Morin J; Bismuth H
    Gastroenterol Clin Biol; 1983 Apr; 7(4):335-9. PubMed ID: 6873546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphological liver changes after portacaval and splenocaval anastomosis in rats].
    Schröder R; Holmin T; Ruchti C; Colombo JP; Peheim E
    Helv Chir Acta; 1979 May; 46(1-2):235-8. PubMed ID: 468574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A series of inhibitors of azo dye hepatocarcinogenesis partially reverse the azo dye-induced decrease in liver RNA/DNA ratio.
    Blunck JM; Smith ML; Vorrath EM
    Res Commun Chem Pathol Pharmacol; 1982 Nov; 38(2):255-69. PubMed ID: 6187053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of 3'-methyl-4-dimethylaminoazobenezene-induced hepatocarcinogenesis by portacaval shunt.
    Fiala S; Pragani B; Reuber MD
    Tumori; 1978 Apr; 64(2):131-42. PubMed ID: 27891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterialization of the liver after portacaval shunt in the rabbit.
    Vassanelli P; Zannini P; Merigliano S; Maruotti RA
    Int Surg; 1980; 65(2):151-5. PubMed ID: 7216658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of hepatocarcinogenesis by sorbitan fatty acid ester, a liver pyruvate kinase activity-reducing substance.
    Yanagi S; Sakamoto M; Takahashi S; Hasuike A; Konishi Y; Kumazawa K; Nakano T
    J Natl Cancer Inst; 1985 Aug; 75(2):381-4. PubMed ID: 3860690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.